Bortezomib Plus Melphalan-Induced Cardiomyopathy Presenting as Sinus Tachycardia and Systolic Heart Failure

Chemotherapy-induced cardiotoxicity is a known condition, however, bortezomib and melphalan do not typically cause cardiotoxicity. With the rise in the use of newer chemotherapeutic agents, it is important to identify and understand the cardiac implications of chemotherapeutic agents. We present a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampat, Parth J, Riaz, Sana, Martinez, Fidel, Aiello, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402422/
https://www.ncbi.nlm.nih.gov/pubmed/32775113
http://dx.doi.org/10.7759/cureus.9488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402422/
https://www.ncbi.nlm.nih.gov/pubmed/32775113
http://dx.doi.org/10.7759/cureus.9488

Ejemplares similares